Human Chorionic Gonadotropin (HCG)

Human Chorionic Gonadotropin (HCG) Research Compound

Human Chorionic Gonadotropin (HCG) is a glycoprotein hormone composed of two non-covalently associated subunits — an alpha subunit shared with other pituitary glycoprotein hormones and a structurally distinct beta subunit conferring receptor specificity. Naturally produced by syncytiotrophoblast cells of the placenta, HCG has become a widely utilized research tool for investigating gonadotropin receptor signaling, luteinizing hormone (LH) pathway dynamics, and reproductive endocrinology mechanisms in controlled preclinical laboratory environments.

Human Chorionic Gonadotropin (HCG) — Mechanism of Action

HCG exerts its biological effects primarily through high-affinity binding to the luteinizing hormone/choriogonadotropin receptor (LHCGR), a G-protein coupled receptor expressed across gonadal and extragonadal tissues. Receptor activation initiates downstream cAMP/PKA signaling cascades, modulating steroidogenesis pathways in Leydig and granulosa cell model systems. This well-characterized receptor interaction profile makes HCG a valuable research tool for examining gonadotropin-dependent signal transduction, testosterone biosynthesis regulation, and follicular development mechanisms in both in vitro and preclinical animal model contexts.

Hum